Marc Schmalzing, Herbert Kellner, Ayman Askari, Javier de Toro Santos, Julio Cesar Vazquez Perez-Coleman, Rosario Foti, Sławomir Jeka, Yannick Allanore, Peter Peichl, Martin Oehri, Neil Betteridge, Cristofer Salvati, Elisa Romero, Ines Brueckmann, Tom Sheeran
{"title":"评估COMPACT研究中风湿病患者使用SDZ ETN(一种依那西普生物类似药)的实际治疗效果:简单的语言总结。","authors":"Marc Schmalzing, Herbert Kellner, Ayman Askari, Javier de Toro Santos, Julio Cesar Vazquez Perez-Coleman, Rosario Foti, Sławomir Jeka, Yannick Allanore, Peter Peichl, Martin Oehri, Neil Betteridge, Cristofer Salvati, Elisa Romero, Ines Brueckmann, Tom Sheeran","doi":"10.1080/1750743X.2025.2493039","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":13328,"journal":{"name":"Immunotherapy","volume":" ","pages":"389-397"},"PeriodicalIF":2.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12091901/pdf/","citationCount":"0","resultStr":"{\"title\":\"Assessing real-world treatment with SDZ ETN (an etanercept biosimilar) in people with rheumatic diseases included in the COMPACT study: a plain language summary.\",\"authors\":\"Marc Schmalzing, Herbert Kellner, Ayman Askari, Javier de Toro Santos, Julio Cesar Vazquez Perez-Coleman, Rosario Foti, Sławomir Jeka, Yannick Allanore, Peter Peichl, Martin Oehri, Neil Betteridge, Cristofer Salvati, Elisa Romero, Ines Brueckmann, Tom Sheeran\",\"doi\":\"10.1080/1750743X.2025.2493039\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":13328,\"journal\":{\"name\":\"Immunotherapy\",\"volume\":\" \",\"pages\":\"389-397\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12091901/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immunotherapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/1750743X.2025.2493039\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/5/12 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunotherapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/1750743X.2025.2493039","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/12 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Assessing real-world treatment with SDZ ETN (an etanercept biosimilar) in people with rheumatic diseases included in the COMPACT study: a plain language summary.
期刊介绍:
Many aspects of the immune system and mechanisms of immunomodulatory therapies remain to be elucidated in order to exploit fully the emerging opportunities. Those involved in the research and clinical applications of immunotherapy are challenged by the huge and intricate volumes of knowledge arising from this fast-evolving field. The journal Immunotherapy offers the scientific community an interdisciplinary forum, providing them with information on the most recent advances of various aspects of immunotherapies, in a concise format to aid navigation of this complex field.
Immunotherapy delivers essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this vitally important area of research. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal''s Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3.